-
1دورية أكاديمية
المؤلفون: Inoue, Miyabi, Yokoyama, Teruhiko
المصدر: Acta Medica Okayama
مصطلحات موضوعية: overactive bladder, randomized crossover study, solifenacin, mirabegron
العلاقة: info:pmid/31649364; https://ousar.lib.okayama-u.ac.jp/files/public/5/57368/20191021164301379169/73_5_387.pdfTest; AA00508441; https://ousar.lib.okayama-u.ac.jp/57368Test
الإتاحة: https://doi.org/10.18926/AMO/57368Test
https://ousar.lib.okayama-u.ac.jp/files/public/5/57368/20191021164301379169/73_5_387.pdfTest
https://ousar.lib.okayama-u.ac.jp/57368Test -
2دورية أكاديمية
المؤلفون: Yamanishi, Tomonori, Kaga, Kanya, Sakata, Koichi, Yokoyama, Teruhiko, Kageyama, Shinji, Fuse, Miki, Tokunaga, Shoji
المصدر: Neurourology & Urodynamics; Feb2020, Vol. 39 Issue 2, p804-812, 9p
مصطلحات موضوعية: OVERACTIVE bladder, URINARY organs, BENIGN prostatic hyperplasia, HIP joint
-
3دورية أكاديمية
المؤلفون: OKAMURA, Kikuo, TAKEI, Mineo, NOJIRI, Yoshikatsu, OTSUKA, Atsushi, TAKAMOTO, Hitoshi, MAEDA, Yoshiko, FUJIMURA, Tetsuya, YOKOYAMA, Teruhiko, GOTOH, Momokazu, HOMMA, Yukio
المصدر: LUTS; May2013, Vol. 5 Issue 2, p55-59, 5p
مصطلحات موضوعية: OVERACTIVE bladder, INJECTIONS, DRUG administration, CATHETERIZATION, POSTOPERATIVE care, THERAPEUTICS
-
4دورية أكاديمية
المؤلفون: Yokoyama, Teruhiko1, Koide, Takao1, Hara, Ryoei1, Fukumoto, Kazuhiko1, Miyaji, Yoshiyuki1, Nagai, Atsushi1
المصدر: Urologia Internationalis. Feb2013, Vol. 90 Issue 2, p161-167. 7p. 4 Charts, 1 Graph.
مصطلحات موضوعية: *MEDICATION safety, *PHARMACODYNAMICS, *OVERACTIVE bladder, *RANDOMIZED controlled trials, *MEDICAL statistics, *CONTROL groups, *THERAPEUTICS
-
5دورية أكاديمية
المؤلفون: Yokoyama, Teruhiko1 (AUTHOR) uroyoko@med.kawasaki-m.ac.jp, Uematsu, Katsutoshi2 (AUTHOR), Watanabe, Toyohiko2 (AUTHOR), Sasaki, Katsumi2 (AUTHOR), Kumon, Hiromi2 (AUTHOR), Nagai, Atsushi1 (AUTHOR), On Behalf Of The Okayama Urological Research Group1 (AUTHOR)
المصدر: Scandinavian Journal of Urology & Nephrology. Sep2009, Vol. 43 Issue 4, p307-314. 8p. 7 Charts, 1 Graph.
مصطلحات موضوعية: *URINARY tract infections, *HYPERPLASIA, *URINARY incontinence, *PROSTATE hypertrophy, *MEDICAL care